Page last updated: 2024-10-29

ketoconazole and Liver Failure, Acute

ketoconazole has been researched along with Liver Failure, Acute in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Liver Failure, Acute: A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, CL1
Hu, JT1
Yang, SS1
Shin, CY1
Huang, SH1

Other Studies

1 other study available for ketoconazole and Liver Failure, Acute

ArticleYear
Unexpected emergence of acute hepatic injury in patients treated repeatedly with ketoconazole.
    Journal of clinical gastroenterology, 2008, Volume: 42, Issue:4

    Topics: Antifungal Agents; Emergencies; Female; Humans; Ketoconazole; Liver Failure, Acute; Mycoses; Prognos

2008